High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 13, Issue 5, 1998, Pages 1206-1210

  Albitar, Sami ^a,b   Genin, Robert ^a   Fen Chong, Michel ^a   Serveaux, Marie Odile ^a   Bourgeon, Bruno ^a  

^a Centre Hospitalier Departemental Felix Guyon   (France)

^b Haemodialysis Centre   (France)

Author keywords

Anaemia; Enalapril; Erythropoietin requirement; Haemodialysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HEMOGLOBIN; NIFEDIPINE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RENAL DIALYSIS;

EID: 0031970298     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.5.1206     Document Type: Article

References (32)

1. Winearls CG, Oliver D, Pipprad MG, Reid C, Dowing MR, Cottes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic dialysis. Lancet 1986; 2: 1175-1177
2. Erslev AJ, Besarab A. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int 1997; 51: 622-630
3. Albitar S, Genin R, Fen-Chong M, Serveaux MO, Schohn D, Chuet C. High-dose alfacalcidol improves anaemia in patients on haemodialysis. Nephrol Dial Transplant 1997; 12: 514-518
4. Albitar S, Meulders Q, Hammoud H, Soutif C, Bouvier P, Pollini J. Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients. Nephrol Dial Transplant 1995; 10 [Suppl 6]: S40-S43
5. Fruncillo RJ, Rocci ML, Vlasses PH et al. Disposition of enalapril and enalaprilat in renal insufficiency. Kidney Int 1987; 31 [Suppl 20]: S117-S122
6. Sennesael J, Verbeelen D. Therapeutic efficacy and tolerance of two orally active angiotensin converting enzyme inhibitors in patients undergoing regular hemodialysis. (abstract) Kidney Int 1985; 28: A252
7. Griffing GT, Melby JC. Enalapril (MK-420) and the white cell count and haematocrit. Lancet 1982; 1: 1361
8. Fyhrquist F, Karppinen K, Honkannen T et al. High serum erythropoietin levels are normalised during treatment of congestive heart failure with enalapril. J Intern Med 1989; 226: 257-260
9. Kamper AL, Nielson OJ. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 1990; 50: 611-618
10. Hirakata H, Onayama K, Iseki K, Kumagai H, Fujimi S, Omae T. Worsening of anemia induced by long-term use of captopril in hemodialysis patients. Am J Nephrol 1984; 4: 355-360
11. Hirakata H, Onayama K, Hori K, Fujishima M. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients. Clin Nephrol 1986; 26: 27-32
12. Onayama K, Sanai T, Motomura K, Fujishima M. Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients. J Cardiovasc Pharmacol. 1989; 13 [Suppl 3]: S27-S30
13. Yoshida A, Morozumi K, Suganuma T et al. Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis. Nephron. 1991; 59: 334-335
14. Vlahakos DV, Canzanello VJ, Madaio MP, Madias NE. Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis. 1991; 17: 199-205
15. Beckingham IJ, Woodrow G, Hinwood M et al. A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation. Nephrol Dial Transplant. 1995; 10: 2316-2320
16. Perazella M, McPhedran P, Kliger A, Lorber M, Levy E, Bia MJ. Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels. Am J Kidney Dis. 1995; 26: 495-500
17. Islam MS, Bourbigot B, Codet JP, Songy B, Fournier G, Cledes J. Captopril induces correction of postrenal transplant erythremia. Transplant Int 1990; 3: 222-225
18. Gaston RS, Julian BA, Barker CV, Diethelm AG, Curtis JJ. Enalapril: safe and effective therapy for posttransplant erythrocytosis. Transplant Proc 1993; 25: 1029-1031
19. Rell K, Koziak K Jarzyo I, Lao M, Grciong Z. Correction of posttransplant erythrocytosis with enalapril. Transplantation. 1994; 57: 1059-1063
20. Conlon PJ, Farrell J, Donohoe J, Camody M, Walshe JJ. The beneficial effect of enalapril on erythropoiesis after renal transplantation. Transplantation 1993; 56: 217-219
21. Rostaing L, Demur C, Huyn A, Durand D, Lloveras JJ, Suc JM. Erythrocytosis after renal transplant. Study of erythroid progenitors and response to enalapril. Transplant Proc 1994; 26: 280-281
22. Walter J. Does captopril decrease the effect of human recombinant erythropoietin in haemodialysis patients? Nephrol Dial Transplant. 1993; 8: 1428
23. Conlon PJ, Albers F, Butterly D, Schwab SJ. ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. Nephrol Dial Transplant 1994; 9: 1358
24. Sanchez JA. ACE inhibitors do not decrease rHuEpo response in patients with end-stage renal failure. Nephrol Dial Transplant 1995; 10: 1476
25. Cruz DN, Perazella MA, Abu-Alfa AK, Mahnensmith RL. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance? Am J Kidney Dis. 1996; 4: 535-540
26. Daugirdas JT. The post/pre plasma urea nitrogen ratio to estimate Kt/V and n PCR: validation. Int J Artif Organs 1989; 12: 420-427
27. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534
28. Nakao K, Shirakura T, Azuma M, Maekawa T. Studies on erythropoietic action of angiotensin II. Blood 1967; 29: 754-760
29. Gould AB, Goodman SA, DeWolf R, Onesti G, Swartz C. Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 1980; 96: 523-534
30. Sunder-Plassmann G, Hörl WH. Erythropoietin and iron. Clin Nephrol 1997; 47: 141-157
31. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334: 420-425
32. Azizi M, Rousseau A, Ezan E et al, Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator n-acetyl- seryl-aspartyl-lysyl-proline. J Clin Invest 1996; 97: 839-844